Bosulif 400 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQT6E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,807
Award facts
- Contract value 100% obligated
- $49,807.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $49.8K firm fixed-price delivery order to AmerSourceBergen Drug Corp for the supply of Bosulif 400 mg tablets (30-count) on January 6, 2026, with completion scheduled for January 28, 2026. The award was made on a competitive, non-set-aside basis to support federal pharmaceutical procurement needs. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc. (doing business as AmerSourceBergen) and serves as a critical pharmaceutical distributor for military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is executed under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at up to $999.9M through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications, vaccines, medical devices, and specialty healthcare commodities to support military treatment facilities and federal healthcare programs worldwide. The contract structure, utilizing firm fixed-price delivery orders, demonstrates the contractor's capability to efficiently fulfill government requirements for essential pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FQT6E?
SPE2DR26FQT6E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FQT6E worth?
The government has obligated $49,807 on SPE2DR26FQT6E.
Is contract SPE2DR26FQT6E an order under another contract?
Yes. SPE2DR26FQT6E is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT6E competed?
The extent of competition for SPE2DR26FQT6E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award